Oct 2026· Journal of Medical Cases· Vol 17, pp. 642 - 650· 0 citations· 43 references
Medicine
TL;DR
The case of a 54-year-old adult patient with a left thalamic DMG, H3 K27-altered, World Health Organization (WHO) grade 4, harboring pathogenic H3F3A K27M, KRAS G12V, and PHF6 mutations is presented and the potential biological implications of a KRAS comutation in this rare entity are discussed.
Abstract
Diffuse midline glioma (DMG) is a highly aggressive central nervous system neoplasm that predominantly affects pediatric populations and is associated with a dismal prognosis. Adult DMGs remain relatively uncommon and continue to pose significant diagnostic and therapeutic challenges. We present the case of a 54-year-old adult patient with a left thalamic DMG, H3 K27-altered, World Health Organization (WHO) grade 4, harboring pathogenic H3F3A K27M, KRAS G12V, and PHF6 mutations. The patient presented with headaches, fatigue, imbalance, dizziness, and slowed dexterity. Imaging demonstrated a heterogeneously enhancing left thalamic lesion extending into the midbrain, with associated edema and third-ventricular compression. Stereotactic biopsy confirmed a DMG, H3 K27-altered. Given the surgically inaccessible location and the high risk of neurologic morbidity, the patient underwent definitive radiotherapy without concurrent temozolomide. Follow-up imaging showed an interval reduction in tumor size, consistent with treatment response; however, a new subependymal ventricular nodule raised concern for possible early dissemination. This case highlights the importance of molecular characterization in adult DMG and discusses the potential biological implications of a KRAS comutation in this rare entity. We also review the evolving literature on adult thalamic DMG, molecular alterations, therapeutic considerations, and emerging targeted therapies, including dordaviprone (ONC201).
Although DMG occurring in the suprasellar region with optic tract involvement is very rare, it should be considered in the differential diagnosis of suprasellar masses.
Rihito Nakazato, Tetsuya Shimizu, A. Teshigawara et al.· Radiology Case Reports· 0 citations
High-grade astrocytoma with piloid features (HGAP) is a recently defined brain tumor entity primarily diagnosed via DNA methylation profiling due to its histological overlap with glioblastoma and pilocytic astrocytoma. We report a 26-year-old man with neurofibromatosis type 1 (NF1) presenting with a high-grade midline...
Tuce Soylemez-Akkurt, Ahmet Erbağcı, Ahmet Faruk Özdemir et al.· Journal of Istanbul Faculty...· 0 citations
Heterogeneity of adult H3 K27-altered DMG is highlighted and patterns of adult H3 K27-altered DMG in cases assessed at autopsy are described in cases assessed at autopsy.
A. Lahrache, H. Reecher, Aleksandra Winiarz et al.· Frontiers in Oncology· 0 citations
A 37-year-old woman who presented with long-standing right temporal-parietal headache and acute worsening with vomiting is reported, highlighting a rare pattern of primary extracranial extension in GBM and suggesting direct contiguous transdural invasion as a plausible route of spread in the absence of prior interventi...
Jian-Hang Lin, Jia-Yi Lin, Jia-Na Zhang et al.· Frontiers in Medicine· 0 citations
Pineal region tumors are rare, accounting for less than 1% of intracranial neoplasms, and often present significant diagnostic challenges. Among them, Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID) represent an uncommon subtype with overlapping radiologic features that may mimic more common pineal le...
SMARCB1-deficient sinonasal carcinoma (SDSC) is a recently characterized and aggressive sinonasal malignancy described predominantly in adults, with only rare reports in patients under 18 years of age and limited radiologic characterization in young children. We present the case of an 8-year-old boy with new-onset visi...
Jonathan Yoon, Amanda Aguilera· Radiology Case Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.